文献速递头颈部肿瘤放疗

医院诊疗量与医师诊疗量对鼻咽癌放疗后生存的关联

Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy.
PubMed 文献 · Radiother Oncol · 2020-07-25

基于台湾全民健康保险研究数据库2001至2017年接受根治性放疗的16,315例新诊断鼻咽癌患者,按医院和医师累计诊疗量四分位分组,采用脆弱Cox回归分析。结果显示医院诊疗量显著预测总生存,医师诊疗量则无独立关联;先进放疗技术亚组中医院量效应显著,二维放疗亚组未观察到量效应。

要点

  • 医院诊疗量显著预测鼻咽癌放疗后总生存,医师诊疗量无独立关联。
  • 先进放疗技术亚组中医院量效应显著,二维放疗亚组未观察到量效应。
  • 鼻咽癌放疗应集中至高诊疗量医院而非高诊疗量医师。

核心结论

  • 在高诊疗量医院接受放疗的鼻咽癌患者总生存更好。
  • 鼻咽癌放疗应集中至高诊疗量医院,而非高诊疗量医师。

研究设计与样本

  • 从台湾全民健康保险研究数据库识别2001至2017年新诊断并接受根治性放疗的鼻咽癌患者。
  • 收集患者、医师和医院的人口学特征、肿瘤治疗及合并症信息。
  • 按治疗提供者的累计医院量和医师量四分位分组。
  • 采用脆弱Cox回归模型检验医院量和医师量对总生存的影响。

主要发现

  • 共识别16,315例鼻咽癌患者,由92家医院的258名医师治疗。
  • 单独分析时,医院量和医师量均与总生存正相关。
  • 在充分考虑患者和提供者特征、医院量、医师量及聚类效应的完全调整模型中,医院量显著预测总生存,医师量则无。
  • 在接受先进技术放疗的患者中,医院量与总生存显著相关。
  • 在二维放疗亚组中未观察到量效应。

临床怎么用

  • 鼻咽癌根治性放疗应优先集中至高诊疗量医院。
  • 医师个人诊疗量不宜作为鼻咽癌放疗集中化的主要依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer patients treated at higher-volume hospitals or by more experienced physicians have better outcomes. However, little is known about the effect of these provider volumes on the prognosis of patients receiving definitive radiotherapy (RT). This study aims to examine the independent association between hospital volume and physician volume in relation to the overall survival (OS) of nasopharyngeal cancer (NPC) patients after RT. METHODS: Patients with newly diagnosed NPC receiving definitive RT between 2001 and 2017 were identified from Taiwan's National Health Insurance Research Database. We collected demographic characteristics of patients, physicians and hospitals, as well as cancer treatment and comorbidities. Patients were categorized into quartiles according to cumulative hospital and physician volumes of their treatment providers. The effects of hospital and physician volumes on OS was examined by the frailty Cox regression model. RESULTS: A total of 16,315 NPC patients treated by 258 physicians in 92 hospitals were identified. When the effects of hospital volume and physician volume on survival were separately examined, both of them were positively associated with OS. In a fully adjusted model considering patient and provider characteristics, hospital volume, physician volume, and clustering effects, it showed that hospital volume significantly predicted OS, while physician volume did not. In patients treated with advanced technique RT, hospital volume was significantly associated with OS. However, volume effect was not observed in 2-D RT subgroup. CONCLUSIONS: NPC patients receiving RT at higher-volume hospitals saw better survival. Treatment for NPC should be centralized to high-volume hospitals rather than high-volume physicians.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lai TY, Yeh CM, Hu YW, et al. Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy. Radiother Oncol. 2020. PMID: 32721420. doi:10.1016/j.radonc.2020.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。